Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGcp Asset Bckd Regulatory News (GABI)

Share Price Information for Gcp Asset Bckd (GABI)

Share Price is delayed by 15 minutes
Get Live Data
64.00    0.00 (0.00%)
Bid:
64.00
Ask:
68.00
Spread: 4.00 (6.25%)
Market Cap: £110.02m
GABI Live PriceLast checked at - London Stock Exchange

Intraday Gcp Asset Bckd Share Chart

Second Capital Distribution Update

18 Nov 2024 07:00

RNS Number : 5837M
GCP Asset Backed Income Fund Ltd
18 November 2024
 

GCP Asset Backed Income Fund Limited

("GABI" or the "Company")

LEI: 213800FBBZCQMP73A815

Second Capital Distribution Update

18 November 2024

The Board announces that in connection with the initial capital distribution announced on 6 November 2024, the Company has compulsory redeemed as at close of business on 15 November 2024 (the "Redemption Date") on a pro rate basis 50,409,977 ordinary shares at a price of 89.33875 pence per share, which was approximately 18.95% of the Company's ordinary shares in issue.

Fractions of ordinary shares produced by the applicable redemption ratio have not been redeemed and therefore the number of shares redeemed in respect of each shareholder has been rounded down to the nearest whole number of shares.

Payments of redemption monies are expected to be effected either through CREST (in the case of ordinary shares held in uncertificated form) or by cheque (in the case of ordinary shares held in certificated form) by 29 November 2024. Any certificates currently in circulation will be superseded by a new certificate which will be distributed to certificated shareholders by 29 November 2024.

Following the redemption, the Company has 215,606,413 ordinary shares in issue. Therefore, the total number of voting rights is 215,606,413 and may be used by shareholders as the denominator for determining if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

The new ISIN, JE00BSY6HT75 (the "New ISIN"), in respect of the remaining shares which have not been redeemed, has been enabled and is available for transactions from 8.00 a.m. on 18 November 2024. CREST will automatically transform any open transactions as at the Redemption Date into the New ISIN.

For further information, please contact:

GCP Asset Backed Income Fund Limited

Alex Ohlsson, Chairman

+44 (0)15 3482 2251

Barclays Bank PLC

Dion Di Miceli

Stuart Muress

James Atkinson

 

+44 (0)20 7623 2323

Gravis Capital Management Limited

Philip Kent

Anthony Curl

Cameron Gardener

+44 (0)20 3405 8500

Burson Buchanan

Helen Tarbet

Henry Wilson

Samuel Adams

 

+44 (0)20 7466 5000

Notes to the Editor

About GABI

GCP Asset Backed Income Fund Limited is a closed ended investment company. Its shares are traded on the Main Market of the London Stock Exchange. Its investment objective is to undertake a managed wind-down of the Company and realise all existing assets in the Company's portfolio in an orderly manner.

The Company's portfolio comprises a diversified portfolio of predominantly UK based asset backed loans which are secured against contracted, predictable medium to long term cash flows and/or physical assets.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDKDLFFZFLFFBV
Date   Source Headline
24th Mar 20227:00 amRNSAnnual Report & Financial Statements
25th Feb 20227:00 amRNSCo-living Group Loan Update
3rd Feb 20227:00 amRNSCo-living Group Loan Update
31st Jan 20227:00 amRNSInvestor Report at 31 December 2021
27th Jan 20227:00 amRNSDividend Declaration
25th Jan 20227:00 amRNSNet Asset Value and Investment Update
22nd Dec 20219:03 amRNSCo-Living 2021 Year End Update
3rd Nov 20217:00 amRNSDividend Declaration
29th Oct 20217:00 amRNSInvestor Report at 30 September 2021
15th Oct 20217:00 amRNSNet Asset Value and Investment Update
28th Sep 20217:00 amRNSHalf-year Report
16th Sep 20217:00 amRNSCo-living Group Loan Update
13th Sep 20217:00 amRNSCo-living Group Loan Update and Net Asset Value
20th Aug 20217:00 amRNSExtension to term of Revolving Credit Facility
30th Jul 20217:00 amRNSInvestor Report at 30 June 2021
22nd Jul 20217:00 amRNSDividend Declaration
15th Jul 20217:00 amRNSNet Asset Value and Investment Update
17th May 20212:13 pmRNSResults of Annual General Meeting
4th May 20217:00 amRNSInvestor Report at 31 March 2021
29th Apr 20215:42 pmRNSDirector/PDMR Shareholding
29th Apr 20217:00 amRNSDividend Declaration
20th Apr 20217:00 amRNSNet Asset Value and Investment Update
16th Apr 20217:00 amRNSNotice of Annual General Meeting
31st Mar 20217:00 amRNSTotal Voting Rights
23rd Mar 20217:00 amRNSAnnual Report & Financial Statements
18th Mar 20217:00 amRNSTransaction in Own Shares
15th Mar 20217:00 amRNSTransaction in Own Shares
12th Mar 20217:00 amRNSTransaction in Own Shares
10th Mar 20217:00 amRNSTransaction in Own Shares
8th Mar 20217:00 amRNSCompliance with Market Abuse Regulation
29th Jan 20217:00 amRNSInvestor Report at 31 December 2020
26th Jan 20217:00 amRNSDividend Declaration & Scrip Dividend Suspension
18th Jan 20217:00 amRNSNet Asset Value and Investment Update
4th Dec 20207:00 amRNSInvestment Manager change of control
30th Nov 20207:00 amRNSTotal Voting Rights
26th Nov 20207:00 amRNSSpecial Dividend Declaration
5th Nov 20207:00 amRNSTransaction in Own Shares
2nd Nov 20207:00 amRNSTransaction in Own Shares
2nd Nov 20207:00 amRNSInvestor Report at 30 September 2020
30th Oct 20207:00 amRNSTransaction in Own Shares
29th Oct 20207:00 amRNSTransaction in Own Shares
28th Oct 20207:00 amRNSTransaction in Own Shares
19th Oct 20207:00 amRNSDividend Declaration & Scrip Dividend Suspension
19th Oct 20207:00 amRNSTransaction in Own Shares
16th Oct 20207:00 amRNSTransaction in Own Shares
15th Oct 20207:00 amRNSNet Asset Value and Investment Update
15th Oct 20207:00 amRNSTransaction in Own Shares
12th Oct 20207:00 amRNSTransaction in Own Shares
8th Oct 20207:00 amRNSTransaction in Own Shares
7th Oct 20207:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.